vancomycin has been researched along with oleylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gannimani, R; Govender, T; Makhathini, S; Mocktar, C; Salih, M; Walvekar, P | 1 |
| Agrawal, N; Govender, T; Mocktar, C; Omolo, CA; Ramdhin, C; Salih, M; Waddad, AY; Walvekar, P | 1 |
2 other study(ies) available for vancomycin and oleylamine
| Article | Year |
|---|---|
Self-assembled oleylamine grafted hyaluronic acid polymersomes for delivery of vancomycin against methicillin resistant Staphylococcus aureus (MRSA).
Topics: Amines; Anti-Bacterial Agents; Cell Survival; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; HEK293 Cells; HeLa Cells; Humans; Hyaluronic Acid; MCF-7 Cells; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Polymers; Vancomycin | 2019 |
Supramolecular amphiphiles of Beta-cyclodextrin and Oleylamine for enhancement of vancomycin delivery.
Topics: A549 Cells; Amines; Anti-Bacterial Agents; beta-Cyclodextrins; Cell Line; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Drug Delivery Systems; HEK293 Cells; HeLa Cells; Humans; Macrophages; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nanoparticles; Nanostructures; Particle Size; Staphylococcal Infections; Th1 Cells; Vancomycin | 2020 |